Workflow
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ImmunomeImmunome(US:IMNM) Businesswire·2025-10-02 21:05

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (the "Company†) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on Oct. 1, 2025, the Compensation Committee of the Company's Board of Directors (the "Compensation Committee†) granted inducement awards consisting of non-statutory stock options to purchase an aggregate of 69,000 shares of common stock to 5 new employees under the Company's 2024 Inducement. ...